Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aimmune Therap
(NQ:
AIMT
)
34.49
USD
UNCHANGED
Last Price
Updated: 7:11 PM EDT, Oct 12, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
34.49
Bid (Size)
34.46 (250)
Ask (Size)
34.51 (2)
Prev. Close
34.49
Today's Range
34.49 - 34.49
52wk Range
10.09 - 34.59
Shares Outstanding
58,095,408
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm
November 19, 2020
From
GlobeNewswire News Releases
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aimmune Therapeutics, Inc. In The Northern District Of California
October 15, 2020
Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06733-YGR, on...
From
PR Newswire
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+0.94%
+0.94%
1 Year
+67.35%
+67.35%
More News
Read More
Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.
October 13, 2020
From
PR Newswire
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
October 02, 2020
From
PR Newswire
Aimmune Presents New Clinical Data From Pooled Safety Analysis in Patients Treated With PALFORZIA® for up to ~3.5 Years
February 25, 2021
From
Business Wire News Releases
Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
September 23, 2020
From
GlobeNewswire News Releases
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – MNTA, VRTU, AIMT, MXIM
September 20, 2020
From
ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Aimmune Therapeutics, Inc. - AIMT
September 18, 2020
From
PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
September 17, 2020
From
PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc
September 16, 2020
From
GlobeNewswire News Releases
Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
October 02, 2020
From
InvestorBrandNetwork
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.